Inrig Jula's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Jan 7, 2026
- Accession no.
- 0001902368-26-000002
- Filed
- Jan 7, 2026
- Trade date
- Jan 5-6, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $98.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Inrig JulaCIK 0001902368 | Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Common Stock | SSaleDisposed | −2,031 | $40.18 | −$81,605.58 | 86,756 | Direct | |
| Jan 6, 2026 | Common Stock | SSaleDisposed | −445 | $37.75 | −$16,798.75 | 86,311 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.